This translation has been automatically generated and has not been verified for accuracy.A person grabs a syringe from a cooler at a COVID-19 vaccine drive-thru clinic at Richardson Stadium in Kingston, Ont., on May 28, 2021. Calgary-based Providence Therapeutics says it has signed two contracts to have its developmental mRNA vaccine made in Canada.
A Phase 2 clinical trial in 525 people is now about to begin to further test the safety and effectiveness of the vaccine. Canada’s lacklustre manufacturing capacity for vaccines was a major issue heading into the COVID-19 vaccination procurement process and the federal government is working to expand the industry.
เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม: